Is Molecular Diagnosis Necessary for Children with Duchenne Muscular Dystrophy?

被引:0
作者
Ratna Dua Puri
机构
[1] Sir Ganga Ram Hospital,Institute of Medical Genetics and Genomics
来源
Indian Pediatrics | 2019年 / 56卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:549 / 550
页数:1
相关论文
共 33 条
[1]  
Falzarano MS(2015)Duchenne muscular dystrophy: From diagnosis to therapy Molecules 20 18168-84
[2]  
Scotton C(2019)Molecular and histopathological characterization of patients presenting with the Duchenne muscular dystrophy phenotype in a tertiary care center in Southern India Indian Pediatr 56 556-9
[3]  
Passarelli C(2018)DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, Part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management Lancet Neurol 17 251-67
[4]  
Ferlini A(2012)Aberrant firing of replication origins potentially explains intragenic nonrecurrent rearrangements within genes, including the human DMD gene Genome Res. 22 25-34
[5]  
Tallapaka K(2016)Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy Acta Myol. 35 122-27
[6]  
Ranganath P(2016)The importance of genetic diagnosis for Duchenne muscular dystrophy J Med Genet. 53 145-51
[7]  
Ramachandran A(2017)Clinical Evaluator Training Group; ACT DMD Study Group. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Lancet 390 1489-98
[8]  
Uppin MS(undefined)undefined undefined undefined undefined-undefined
[9]  
Perala S(undefined)undefined undefined undefined undefined-undefined
[10]  
Aggarwal S(undefined)undefined undefined undefined undefined-undefined